ELTP ready for its annual trip to the moon; one year ago @ .97 and more products launched; company at the cusp of FDA 'greenlight' submission of ELI-200 first of 17 generic abuse deterrent opioids; plant expansion and staff expansion; ten qtrs. of positive cash flow; debt reduction completed; will fly past .97.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.